The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate

Introduction: The anti-fibrotic hormone, relaxin, has been inferred to disrupt transforming growth factor (TGF)-β1/Smad2 phosphorylation (pSmad2) signal transduction and promote collagen-degrading gelatinase activity via a nitric oxide (NO)-dependent pathway. Here, we determined the extent to which...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Kemp-Harper, Barbara K., Kocan, Martina, Ang, Sheng Yu, Hewitson, Tim D., Samuel, Chrishan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815292/
https://www.ncbi.nlm.nih.gov/pubmed/27065874
http://dx.doi.org/10.3389/fphar.2016.00091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815292/
https://www.ncbi.nlm.nih.gov/pubmed/27065874
http://dx.doi.org/10.3389/fphar.2016.00091

Ejemplares similares